|
1
|
Perencevich M and Stoffel EM: A
multidisciplinary approach to the diagnosis and management of
multiple colorectal polyps. Gastroenterol Hepatol (NY). 7:420–423.
2011.
|
|
2
|
Shelton BK: Introduction to colorectal
cancer. Semin Oncol Nurs. 18(Suppl 2): S2–S12. 2002. View Article : Google Scholar
|
|
3
|
Shimada H, Tanaka K, Endou I and Ichikawa
Y: Treatment for colorectal liver metastases: A review. Langenbecks
Arch Surg. 394:973–983. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al-Maghrabi J, Emam E, Gomaa W, Saggaf M,
Buhmeida A, Al-Qahtani M and Al-Ahwal M: c-MET immunostaining in
colorectal carcinoma is associated with local disease recurrence.
BMC Cancer. 15:6762015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jagadish N, Parashar D, Gupta N, Agarwal
S, Purohit S, Kumar V, Sharma A, Fatima R, Topno AP, Shaha C and
Suri A: A-kinase anchor protein 4 (AKAP4) a promising therapeutic
target of colorectal cancer. J Exp Clin Cancer Res. 34:1422015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar
|
|
7
|
Boland CR and Goel A: Microsatellite
instability in colorectal cancer. Gastroenterology. 138:2073–2087.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elzagallaai AA, Garcia-Bournissen F,
Finkelstein Y, Bend JR, Rieder MJ and Koren G: Severe bullous
hypersensitivity reactions after exposure to carbamazepine in a
Han-Chinese child with a positive HLA-B*1502 and
negative in vitro toxicity assays: Evidence for different
pathophysiological mechanisms. J Popul Ther Clin Pharmacol.
18:e1–e9. 2011.
|
|
9
|
Raychaudhuri P and Park HJ: FoxM1: A
master regulator of tumor metastasis. Cancer Res. 71:4329–4333.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kalin TV, Ustiyan V and Kalinichenko VV:
Multiple faces of FoxM1 transcription factor: Lessons from
transgenic mouse models. Cell Cycle. 10:396–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang IC, Chen YJ, Hughes D, Petrovic V,
Major ML, Park HJ, Tan Y, Ackerson T and Costa RH: Forkhead box M1
regulates the transcriptional network of genes essential for
mitotic progression and genes encoding the SCF (Skp2-Cks1)
ubiquitin ligase. Mol Cell Biol. 25:10875–10894. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun H, Teng M, Liu J, Jin D, Wu J, Yan D,
Fan J, Qin X, Tang H and Peng Z: FOXM1 expression predicts the
prognosis in hepatocellular carcinoma patients after orthotopic
liver transplantation combined with the Milan criteria. Cancer
Lett. 306:214–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu J, Deshmukh H, Payton JE, Dunham C,
Scheithauer BW, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner RE,
et al: Array-based comparative genomic hybridization identifies
CDK4 and FOXM1 alterations as independent predictors of survival in
malignant peripheral nerve sheath tumor. Clin Cancer Res.
17:1924–1934. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Balli D, Zhang Y, Snyder J, Kalinichenko
VV and Kalin TV: Endothelial cell specific deletion of
transcription factor FoxM1 increases urethane-induced lung
carcinogenesis. Cancer Res. 71:40–50. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calvisi DF, Pinna F, Ladu S, Pellegrino R,
Simile MM, Frau M, De Miglio MR, Tomasi ML, Sanna V, Muroni MR, et
al: Forkhead box M1B is a determinant of rat susceptibility to
hepatocarcinogenesis and sustains ERK activity in human HCC. Gut.
58:679–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Chen GQ, Tang CF, Shi XK, Lin CY, Fatima
S, Pan XH, Yang DJ, Zhang G, Lu AP, Lin SH and Bian ZX:
Halofuginone inhibits colorectal cancer growth through suppression
of Akt/mTORC1 signaling and glucose metabolism. Oncotarget.
6:24148–24162. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rasool S, Kadla SA, Rasool V and Ganai BA:
A comparative overview of general risk factors associated with the
incidence of colorectal cancer. Tumour Biol. 34:2469–2476. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Van Cutsem E, Nordlinger B, Adam R, Köhne
CH, Pozzo C, Poston G, Ychou M and Rougier P; European Colorectal
Metastases Treatment Group: Towards a pan-European consensus on the
treatment of patients with colorectal liver metastases. Eur J
Cancer. 42:2212–2221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poston GJ, Figueras J, Giuliante F, Nuzzo
G, Sobrero AF, Gigot JF, Nordlinger B, Adam R, Gruenberger T, Choti
MA, et al: Urgent need for a new staging system in advanced
colorectal cancer. J Clin Oncol. 26:4828–4833. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lam EW, Brosens JJ, Gomes AR and Koo CY:
Forkhead box proteins: Tuning forks for transcriptional harmony.
Nat Rev Cancer. 13:482–95. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai Y, Balli D, Ustiyan V, Fulford L,
Hiller A, Misetic V, Zhang Y, Paluch AM, Waltz SE, Kasper S and
Kalin TV: Foxm1 expression in prostate epithelial cells is
essential for prostate carcinogenesis. J Biol Chem.
288:22527–22541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan Q, Cai Q and Xu Y: FOXM1 is a
downstream target of LPA and YAP oncogenic signaling pathways in
high grade serous ovarian cancer. Oncotarget. 6:27688–27699. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu G, Zhou A, Xue J, Huang C, Zhang X,
Kang SH, Chiu WT, Tan C, Xie K, Wang J and Huang S: FoxM1 promotes
breast tumorigenesis by activating PDGF-A and forming a positive
feedback loop with the PDGF/AKT signaling pathway. Oncotarget.
6:11281–11294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Consolaro F, Basso G, Ghaem-Magami S, Lam
EW and Viola G: FOXM1 is overexpressed in B-acute lymphoblastic
leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to
chemotherapeutic drugs. Int J Oncol. 47:1230–1240. 2015.PubMed/NCBI
|
|
26
|
Barger CJ, Zhang W, Hillman J, Stablewski
AB, Higgins MJ, Vanderhyden BC, Odunsi K and Karpf AR: Genetic
determinants of FOXM1 overexpression in epithelial ovarian cancer
and functional contribution to cell cycle progression. Oncotarget.
6:27613–27627. 2015. View Article : Google Scholar : PubMed/NCBI
|
